Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001171843-16-009195
Filing Date
2016-04-15
Accepted
2016-04-15 13:35:28
Documents
57
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A f10ka_041516.htm 10-K/A 55441
2 EXHIBIT 31.1 exh_311.htm EX-31.1 3018
3 EXHIBIT 31.2 exh_312.htm EX-31.2 2680
  Complete submission text file 0001171843-16-009195.txt   2915061

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE xbit-20151231.xml EX-101.INS 607223
5 XBRL SCHEMA FILE xbit-20151231.xsd EX-101.SCH 42804
6 XBRL CALCULATION FILE xbit-20151231_cal.xml EX-101.CAL 32135
7 XBRL DEFINITION FILE xbit-20151231_def.xml EX-101.DEF 284346
8 XBRL LABEL FILE xbit-20151231_lab.xml EX-101.LAB 267552
9 XBRL PRESENTATION FILE xbit-20151231_pre.xml EX-101.PRE 309064
Mailing Address 8201 E. RIVERSIDE DRIVE BUILDING 4, SUITE 100 AUSTIN TX 78744
Business Address 8201 E. RIVERSIDE DRIVE BUILDING 4, SUITE 100 AUSTIN TX 78744 512-386-2930
XBiotech Inc. (Filer) CIK: 0001626878 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-37347 | Film No.: 161573922
SIC: 2834 Pharmaceutical Preparations